BlackRock Amends Dexcom Stake: Passive Investment Update

TL;DR

**BlackRock updated its Dexcom stake, signaling a passive investment adjustment.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating a change in its ownership stake in Dexcom Inc. as of December 31, 2023. This filing, Amendment No. 6, shows BlackRock continues to hold a significant, though potentially adjusted, passive investment in Dexcom's Common Stock. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or strategy regarding Dexcom's future performance.

Why It Matters

Large institutional investors like BlackRock can influence stock prices and company direction, so changes in their holdings are closely watched by the market.

Risk Assessment

Risk Level: low — This filing is a routine update from a passive investor and does not indicate any immediate or significant risk to the company or its stock.

Analyst Insight

Investors should note that BlackRock maintains a passive stake in Dexcom. While this filing doesn't reveal specific share count changes, it confirms BlackRock's continued interest. Smart investors might monitor future 13F filings for more detailed share count adjustments by BlackRock, as well as Dexcom's upcoming earnings reports for operational performance insights.

Key Players & Entities

• BlackRock Inc. (company) — the reporting person and institutional investor
• DEXCOM INC (company) — the subject company whose securities are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• January 25, 2024 (date) — the filing date of the SC 13G/A
• Amendment No: 6 (number) — the specific amendment number of the filing

FAQ

From the Filing

0001086364-24-003316.txt : 20240125 0001086364-24-003316.hdr.sgml : 20240125 20240125134852 ACCESSION NUMBER: 0001086364-24-003316 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81357 FILM NUMBER: 24561076 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us2521311074_012524.txt us2521311074_012524.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 6) DEXCOM INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 252131107 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 252131107 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 29963722 (6) Shared voting power 0 (7) Sole dispositive power 32851473 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 32851473 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 8.5% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- DEXCOM INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 6340 SEQUENCE DRIVE San Diego CA 92121 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ------------------------------